YOSHIO YAMAOKA to Cost-Benefit Analysis
This is a "connection" page, showing publications YOSHIO YAMAOKA has written about Cost-Benefit Analysis.
Connection Strength
0.091
-
Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond. Drugs. 2008; 68(6):725-36.
Score: 0.057
-
Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus. Gut. 2020 12; 69(12):2093-2112.
Score: 0.034